Tendons - Time to revisit inflammation

British Journal of Sports Medicine

Volumn 48, Issue 21, 2014, Pages 1553-1557

  Rees, Jonathan D ^a   Stride, Matthew ^b   Scott, Alex ^c  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b FIFA MEDICAL CENTRE OF EXCELLENCE   (Switzerland)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; SUBSTANCE P; TUMOR NECROSIS FACTOR;

ANTAGONISTS AND INHIBITORS; CHRONIC DISEASE; HUMAN; MUSCULOSKELETAL PAIN; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TENDINOPATHY; TENDON; VASCULARIZATION;

ANTI-INFLAMMATORY AGENTS; CHRONIC DISEASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; HUMANS; MATRIX METALLOPROTEINASE INHIBITORS; MATRIX METALLOPROTEINASES; MUSCULOSKELETAL PAIN; NEOVASCULARIZATION, PATHOLOGIC; SUBSTANCE P; TENDINOPATHY; TENDONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84908875233     PISSN: 03063674     EISSN: 14730480     Source Type: Journal    
DOI: 10.1136/bjsports-2012-091957     Document Type: Article

References (73)

1. Khan KM, Cook JL, Maffulli N, et al. Time to abandon the "tendinitis" myth. BMJ 2002;16:626-7.
2. Rees JD, Wilson AM, Wolman RL. Current concepts in the management of tendon disorders. Rheumatology 2006;45:508-21.
3. Rees JD, Maffulli N, Cook J. Management of tendinopathy. Am J Sports Med 2009;37:1855-67.
4. Puddu G, Ippolito E, Postacchini F. A classification of Achilles tendon disease. Am J Sports Med 1976;4:145-50.
5. Aström M, Rausing A. Chronic Achilles tendinopathy. A survey of surgical and histopathologic findings. Clin Orthop Relat Res 1995;316:151-64.
6. Józsa L, Kannus P. Histopathological findings in spontaneous tendon ruptures. Scand J Med Sci Sports 1997;2:113-18.
7. Khan KM, Cook JL, Bonar F, et al. Histopathology of common tendinopathies. Update and implications for clinical management. Sports Med 1999;27:393-408.
8. Zamora AJ, Marini JF. Tendon and myo-tendinous junction in an overloaded skeletal muscle of the rat. Anat Embryol (Berl) 1988;179:89-96.
9. Clancy W. Failed healing responses. In: Leadbetter W, Buckwater J, Gordon S, eds. Tendon trauma and overuse injuries. Park Ridge, IL: American Orthopedic Society for Sports Medicine, 1989, 609-18.
10. Cook JL, Puram CR. Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. Br J Sports Med 2009;43:409-16.
11. Alfredson H, Pietila T, Jonsson P, et al. Heavy-load eccentric calf muscle training for the treatment of chronic Achilles tendinosis. Am J Sports Med 1998;26:360-6.
12. Rompe JD, Nafe B, Furia JP, et al. Eccentric loading, shock-wave treatment, or a wait-and-see policy for tendinopathy of the main body of tendo Achilles: a randomized controlled trial. Am J Sports Med 2007;35:374-83.
13. Larsson ME, Käll I, Nilsson-Helander K. Treatment of patellar tendinopathy - a systematic review of randomized controlled trials. Knee Surg Sports Traumatol Arthrosc 2012;20:1632-46.
14. Cardoso de Souza M, Trajano Jorge R, Jones A, et al. Progressive resistance training in patients with shoulder impingement syndrome: literature review. Reumatismo 2009;61:84-9.
15. Raman J, MacDermid JC, Grewal R. Effectiveness of different methods of resistance exercises in lateral epicondylosis - a systematic review. J Hand Ther 2011;25:5-25.
16. Silbernagel KG, Thomeé R, Thomeé P, et al. Eccentric overload training for patients with chronic Achilles tendon pain - a randomised controlled study with reliability testing of the evaluation methods. Scand J Med Sci Sports 2001;11:197-206.
17. Kongsgaard M, Kovanen V, Aagaard P, et al. Corticosteroid injections, eccentric decline squat training and heavy slow resistance training in patellar tendinopathy. Scan J Med Sci Sports 2009;19:790-802.
18. Smith RK. Mesenchymal stem cell therapy for equine tendinopathy. Disabil Rehabil 2008;30:1752-8.
19. Kaux JF, Forthomme B, Le Goff C, et al. Current opinions on tendinopathy. J Sport Sci Med 2011;10:238-53.
20. Suresh SPS, Ali KE, Jones H, et al. Is ultrasound guided autologous blood injection an effective treatment? Br J Sports Med 2006;40:935-39.
21. Connell DA, Ali KE, Ahmad M, et al. Ultrasound-guided autologous blood injection for tennis elbow. Skeletal Radiol 2006;35:371-7.
22. De Vos RJ, Weir A, van Schie HTM, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy. JAMA 2010;303:144-9.
23. Alfredson H, Ohberg L, Forsgren S. Is vasculo-neural ingrowth the cause of pain in chronic Achilles tendinosis? An investigation using ultrasonography and colour Doppler, immunohistochemistry, and diagnostic injections. Knee Surg Sports TraumatolArthrosc 2003;11:334-8.
24. Alfredson H, Öhberg L. Sclerosing injections to areas of neo-vascularisation reduce pain in chronic Achilles tendinopathy: a double-blind randomised controlled trial. Knee Surg Sports Traumatol Arthrosc 2005;13:338-44.
25. Chan O, O'Dowd D, Padhiar N, et al. High volume image guided injections in chronic Achilles tendinopathy. Disabil rehabil 2008;30:1697-708.
26. Maffulli N, Longo UG, Denaro V. Novel approaches for the management of tendinopathy. J Bone Joint Surg Am 2010;92:2604-13.
27. Schubert TE, Weidler C, Lerch K, et al. Achilles tendinosis is associated with sprouting of substance P positive nerve fibres. Ann Rheum Dis 2005;64:1083-6.
28. Gotoh M, Hamada K, Yamakawa H, et al. Significance of granulation tissue in torn supraspinatus insertions: an immunohistochemical study with antibodies against interleukin-1 beta, cathepsin D, and matrix metalloprotease-1. J Orthop Res 1997;15:33-9.
29. Sullo A, Maffulli N, Capasso G, et al. The effects of prolonged peritendinous administration of PGE1 to the rat Achilles tendon: a possible animal model of chronic Achilles tendinopathy. J Orthopaed Sci 2001;6:349-57.
30. Zhang J, James H-C. Wang production of PGE2 increases in tendons subjected to repetitive mechanical loading and induces differentiation of tendon stem cells into non-tenocytes. J Orthop Res 2010;28:198-203.
31. Khan MH, Li Z, Wang JH. Repeated exposure of tendon to prostaglandin-E2 leads to localized tendon degeneration. Clin J Sport Med 2005;15:27-33.
32. Legerlotz K, Jones ER, Screen HR, et al. Increased expression of IL-6 family members in tendon pathology. Rheumatology (Oxford) 2012;51:1161-5.
33. Fenwick SA, Hazleman BL, Harrall RL, et al. Transforming growth factor-β isoform expression in chronic Achilles tendinopathy and their effects on tendon cell populations. Int J Exp Pathol 2000;81:A11-12.
34. Gotoh M, Hamada K, Yamakawa H, et al. Increased substance P in subacromial bursa and shoulder pain in rotator cuff diseases. J Orthop Res 1998;16:618-21.
35. Backman C, Boquist L, Fridén J, et al. Chronic Achilles paratenonitis with tendinosis: an experimental model in the rabbit. J Orthop Res 1990;8:541-7.
36. Scott A, Cook JL, Hart DA, et al. Tenocyte responses to mechanical loading in vivo: a role for local insulin-like growth factor 1 signaling in early tendinosis in rats. Arthritis Rheum 2007;56:871-81.
37. Nakamura H, Yoshino S, Kato T, et al. T-cell mediated inflammatory pathway in osteoarthritis. Osteoarthritis Cartilage, 1999;7:401-2.
38. Shen PC, Wu CL, Jou IM, et al. T helper cells promote disease progression of osteoarthritis by inducing macrophage inflammatory protein-1γ. Osteoarthritis Cartilage 2011;19:728-36.
39. Huss RS, Huddleston JI, Goodman SB, et al. Synovial tissue-infiltrating natural killer cells in osteoarthritis and periprosthetic inflammation. Arthritis Rheum 2010;62:3799-805.
40. Rees JD, Pilcher J, Heron C, et al. A comparison of clinical vs ultrasound determined synovitis in rheumatoid arthritis utilizing gray-scale, power Doppler and the intravenous microbubble contrast agent 'Sono-Vue'. Rheumatology (Oxford) 2007;46:454-9.
41. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003;9:653-60.
42. Taylor PC, Steuer A, Cosgrove DO, et al. Comparison of ultrasonographic assesment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis. Arthritis Rheum 2004;50:1107-16.
43. Andersson G, Backman LJ, Scott A, et al. Substance P accelerates hypercellularity and angiogenesis in tendon tissue and enhances paratendinitis in response to Achilles tendon overuse in a tendinopathy model. Br J Sports Med 2011;45:1017-22.
44. Riley GP, Curry V, DeGroot J, et al. Matrix metalloproteinase activities and their relationship with collagen remodelling in tendon pathology. Matrix Biol 2002;21:185-95.
45. Riley G. The pathogenesis of tendinopathy. A molecular perspective. Rheumatology 2004;43:131-42.
46. Magra M, Maffulli N. -Matrix metalloproteases: a role in overuse tendinopathies. Br J Sports Med 2005;39:789-91.
47. Fong G, Backman LJ, Hart DA, et al. Substance P enhances collagen remodeling and MMP-3 expression by human tenocytes. J Orthop Res 2013;31:91-8.
48. Garrett NE, Mapp PI, Cruwys SC, et al. Role of substance P in inflammatory arthritis. Ann Rheum Dis 1992;51:1014-18.
49. Capasso G, Testa V, Maffulli N, et al. Aprotinin, corticosteroids and normosaline in the management of patellar tendinopathy in athletes; a prospective randomized study. Sports Exerc Inj 1997;3:111-15.
50. Fredberg U, Ostgaard R. Effect of ultrasound-guided, peritendinous injections of adalimumab and anikinra in chronic Achilles tendinopathy. Scan J Med Sci Sports 2009;19:338-44.
51. Nimgade A, Sullivan M, Goldman R. Physiotherapy, steroid injections, or rest for lateral epicondylosis? What the evidence suggests. Pain Pract 2005;5:203-15.
52. Bisset L, Beller E, Jull G, et al. Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trial. BMJ 2006;333:939.
53. DaCruz DJ, Geeson M, Allen MJ, et al. Achilles paratendonitis: an evaluation of steroid injection. Br J Sports Med 1988;22:64-5.
54. Gill SS, Gelbke MK, Mattson SL, et al. Fluoroscopically guided low-volume peritendinous corticosteroid injection for Achilles tendinopathy. A safety study. J Bone Joint Surg Am 2004;86:802-6.
55. Buchbinder R, Green S, Youd JM. Corticosteroid injections for shoulder pain. Cochrane Database Syst Rev 2003;(1):CD004016.
56. Kleinman M, Gross AE. Achilles tendon rupture following steroid injection: report of three cases. J Bone Joint Surg Am 1983;65:1345-7.
57. Ford LT, DeBender J. Tendon rupture after local steroid injection. South Med J 1979;72:827-30.
58. Almekinders LC, Temple JD. Etiology, diagnosis, and treatment of tendonitis: an analysis of the literature. Med Sci Sports Exerc 1998;30:1183-90.
59. Andres BM, Murrell GA. Treatment of tendinopathy: What works, what does not, and what is on the horizon. Clin Orthop Relat Res 2008;466:1539-54.
60. McLauchlan G, Handoll HHG. Interventions for treating acute and chronic Achilles tendinitis. Editorial Group: Cochrane Bone, Joint and Muscle Trauma Group. Published Online: 21 Jan 2009 Assessed as up-to-date: 29 Dec 2000.
61. Lanas A, Perez-Aisa MA, Feu F, et al. A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use. Am J Gastroenterol 2005;100:1685-93.
62. Feldmann M, Maini RN. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Ann Rev Immunol 2001;19:163-96.
63. Rath CC, Aggarwal BB. TNF-induced signalling in apoptosis. J Clin Immunol 1999;19:350-64.
64. Fallon K, Purdam C, Cook J, et al. A "polypill" for acute tendon pain in athletes with tendinopathy?. J Sci Med Sport 2008;11:235-8.
65. Corps AN, Robinson AH, Movin T, et al. Versican splice variant messenger RNA expression in normal human Achilles tendon and tendinopathies. Rheumatology (Oxford) 2004;43:969-72.
66. Jones GC, Corps AN, Pennington CJ, et al. Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human Achilles tendon. Arthritis Rheum 2006;54:832-42.
67. Karousou E, Ronga M, Vigetti D, et al. Collagens, proteoglycans, MMP-2, MMP-9 and TIMPs in human Achilles tendon rupture. Clin Orthop Relat Res 2008;466:1577-82.
68. Deng H, O'Keefe H, Davie CP, et al. Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT). J Med Chem 2012;55:7061-79.
69. Backman LJ, Andersson G, Wennstig G, et al. Endogenous substance P production in the Achilles tendon increases with loading in an in vivo model of tendinopathy-peptidergic elevation preceding tendinosis-like tissue changes. J Musculoskelet Neuronal Interact 2011;11:133-40.
70. Alfredson H, Thorsen K, Lorentzon R. In situ microdialysis in tendon tissue: high levels of glutamate, but not prostaglandin E2 in chronic Achilles tendon pain. Knee Surg Sports Traumatol Arthrosc 1999;7:378-81.
71. Carlsson NS, Li J, et al. Substance P injections enhance tissue proliferation and regulate sensory nerve ingrowth in rat tendon repair. Scand J Med Sci Sports 2011;4:562-9.
72. Merighi A. Neuropeptides and coexistence. In: Intercellular communication in the nervous system ed robert malenka, London: Academic Press, Elsevier, 2009:525-9.
73. Bagge J, Lorentzon R, Alfredson H, et al. Unexpected presence of the neurotrophins NGF and BDNF and the neurotrophin receptor p75 in the tendon cells of the human Achilles tendon. Histol Histopathol 2009;24:839-48.